Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

2
Markets Live: ASX opens higher on modest gains

2018-07-09 smh.com.au
Most fund managers assessing a company like Cabcharge Australia would follow a tried and tested model: read the financial statements, consider the earnings outlook, evaluate the industry structure and intensity of competition.
IAUGY RIO BLT RIO BHPBF IAG CBRGF RTPPF IAUGF BHP RIO RTNTF CGAAY INCZY BBL BHP BHPLF ICPVF IPL CAB

2
Markets Live: ASX opens higher on modest gains

2018-07-09 theage.com.au
The Australian sharemarket has advanced at the open this morning although most index heavyweights are still trading cautiously.
IAUGY RIO BLT RIO BHPBF IAG RTPPF IAUGF BHP RIO RTNTF INCZY BBL BHP BHPLF ICPVF IPL

2
Australian shares advance on strength of major banks

2018-07-03 theage.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

2
Australian shares advance on strength of major banks

2018-07-03 smh.com.au
The Australian sharemarket has recorded only its second advance in the last eight sessions despite a broad retreat of commodity prices overnight.
PILBF RIO DB BLT RIO IAG MS.PRE MS.PRF MS.PRG MS.PRA BEPTF RTPPF GALXF RTNTF MS TWE SML IAUGY PLS TSRYY BHPBF EBOSY EBO BCHEY BPT EBOSF TSRYF GXY IAUGF MS.PRI BHP RIO MS.PRK BBL BHP BHPLF EBO

0
NZ's biggest insurer ditches staff sales targets

2018-06-28 nzherald.co.nz
Insurance Australia Group - New Zealand's largest general insurer - is to stop incentivising its staff using sales targets.
IAUGY IAUGF IAG

18
ASX ends stellar week on softer note

2018-06-22 theage.com.au
Australian shares ended a stellar week on a lower note, as caution crept into the market after traders pushed the index to a level not seen for ten years earlier in the week.
IAUGY FBU FCREY MS.PRE IAG MS.PRF MS.PRG MS.PRA FRCEF MAYNF IAUGF MS.PRI FBU MS.PRK MS

18
ASX ends stellar week on softer note

2018-06-22 smh.com.au
Australian shares ended a stellar week on a lower note, as caution crept into the market after traders pushed the index to a level not seen for ten years earlier in the week.
IAUGY FBU FCREY MS.PRE IAG MS.PRF MS.PRG MS.PRA FRCEF MAYNF IAUGF MS.PRI FBU MS.PRK MS

11
Deals of the day-Mergers and acquisitions

2018-06-19 reuters
June 19 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1130 GMT on Tuesday:
IAUGY DB TKOMF AGODY IAG MALRY MIN AGO IAUGF ATLGF 8766 TKOMY MALRF FMI

17
ASX edges lower on Trump's Chinese tariff threats

2018-06-19 theage.com.au
The Australian sharemarket closed slightly lower on Tuesday after US President Donald Trump threatened to impose more tariffs on China.
IAUGY ASXFF MQBKY SPRRY AGODY IAG MALRY MS.PRE MS.PRF MS.PRG MCQEF MS.PRA MAYNF MIN AGO IAUGF MS.PRI SUL ASXFY MS.PRK ATLGF MALRF MS MQG

17
ASX edges lower on Trump's Chinese tariff threats

2018-06-19 smh.com.au
The Australian sharemarket closed slightly lower on Tuesday after US President Donald Trump threatened to impose more tariffs on China.
IAUGY ASXFF MQBKY SPRRY AGODY IAG MALRY MS.PRE MS.PRF MS.PRG MCQEF MS.PRA MAYNF MIN AGO IAUGF MS.PRI SUL ASXFY MS.PRK ATLGF MALRF MS MQG

0
IAG expects $200m profit from Asian sales

2018-06-18 perthnow.com.au
Insurance Australia Group (IAG) expects to realise an after-tax profit of at least $200 million from the sale of three Asian interests.
IAUGY IAUGF IAG

0
IAG to sell Thai, Indonesian units to Tokio Marine for $525m

2018-06-18 theage.com.au
Insurance Australia Group said it would sell its Thai and Indonesian operations to Japanese insurer Tokio Marine Holdings for $525 million.
IAUGY IAUGF TKOMF IAG 8766 TKOMY

0
IAG to sell Thai, Indonesian units to Tokio Marine for $525m

2018-06-18 smh.com.au
Insurance Australia Group said it would sell its Thai and Indonesian operations to Japanese insurer Tokio Marine Holdings for $525 million.
IAUGY IAUGF TKOMF IAG 8766 TKOMY

2
AMMB looking to divest some assets this year

2018-06-12 theedgemarkets
AMMB Holdings Bhd may divest some assets this year, which could include its 51% stake in AmGeneral Holdings Bhd, as the banking group looks to streamline operations and free up capital.
IAUGY 1023 1015 PFG IAUGF IAG AMMHF CIMDF

1
SBI loss widens over bad loan provisions

2018-05-23 freepressjournal.in
New Delhi : State Bank of India (SBI), the country’s largest lender, on Tuesday reported its deepest-ever quarterly net loss due to sharp rise in provisioning for bad loans.
IAUGY IAUGF IAG SBAZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:IAG / INSURANCE AUSTRALIA GROUP LIMITED on message board site Silicon Investor.

Decision Diagnostics Corp (OTC: DECN) Russiagate!
IAMGOLD Corp Prostitution--the cement that binds marriage
NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) Quest Diagnostics DGX
Gay Marriage QIAGEN (QGENF) - Star of Germanyu0027s Biotechs
QDEL - Quidel more quick diagnosis Hypertension Diagnostics Inc (HDII)